CytoSorbents closes oversubscribed rights offering, raises $6.25M, unlocks $5M restricted cash

Cytosorbents Corp

Rights offering raised $6.25M gross from all 6.25M Units; oversubscribed 68% with 10.5M Units demanded.
Proceeds satisfy debt covenant, releasing $5.0M of restricted cash; net liquidity increase ~$10.8M.
Preliminary unaudited cash (incl. restricted) at Dec 31, 2024: $9.6M; pro forma $15.4M unrestricted $13.9M.
Q4 2024 cash burn est. $2.6M vs Q3 $2.7M; full audited results expected March 6, 2025.
Right Warrants exercisable at 90% of VWAP; Series A floor $1.00 cap $2.00, Series B floor $2.00 cap $4.00.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.